MONTREAL, Oct. 1 /CNW Telbec/ - Haemacure Corporation (TSX: HAE)
announced today the appointment of Thomas J. Lynch, J.D., Ph.D. to the
Company's Board of Directors. Dr. Lynch, former Deputy Director, Division of
Hematology, Office of Blood Research and Review, Center for Biologics
Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA),
currently serves as Senior Vice President Compliance, Regulatory Affairs and
Public Policy for Talecris Biotherapeutics.
